Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5 Suppl
|
pubmed:dateCreated |
1997-7-10
|
pubmed:abstractText |
Resuscitation with hypertonic saline/dextran (HSD) has been suggested to be efficacious in patients who have traumatic brain injury and are hypotensive. We undertook a cohort analysis of individual patient data from previous prospective randomized double-blinded trials to evaluate improvements in survival at 24 hours and discharge after initial treatment with HSD in patients who had traumatic brain injury (head region Abbreviated Injury Score > or = 4) and hypotension (systolic blood pressure < or = 90 mm Hg).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-5282
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S61-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9191698-Abbreviated Injury Scale,
pubmed-meshheading:9191698-Adult,
pubmed-meshheading:9191698-Brain Injuries,
pubmed-meshheading:9191698-Dextrans,
pubmed-meshheading:9191698-Double-Blind Method,
pubmed-meshheading:9191698-Humans,
pubmed-meshheading:9191698-Hypotension,
pubmed-meshheading:9191698-Logistic Models,
pubmed-meshheading:9191698-Plasma Substitutes,
pubmed-meshheading:9191698-Prospective Studies,
pubmed-meshheading:9191698-Randomized Controlled Trials as Topic,
pubmed-meshheading:9191698-Saline Solution, Hypertonic,
pubmed-meshheading:9191698-Survival Analysis
|
pubmed:year |
1997
|
pubmed:articleTitle |
Individual patient cohort analysis of the efficacy of hypertonic saline/dextran in patients with traumatic brain injury and hypotension.
|
pubmed:affiliation |
Medisan Pharmaceuticals Inc., Uppsala, Sweden.
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|